These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2952309)

  • 1. [Nimodipine, nifedipine and vincamine improve amnesia induced by anisodine and sodium nitrite in rats and mice].
    Qin WC; Zhang JT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Oct; 8(5):366-70. PubMed ID: 2952309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of three cerebral vasodilators--nimodipine, nifedipine and vincamine on chemically-induced amnesia in rodents].
    Cheng XJ; Zhang JT
    Yao Xue Xue Bao; 1986 Oct; 21(10):731-5. PubMed ID: 3577770
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of VA-045 on learning and memory deficits in traumatic brain injury (TBI)-induced retrograde and anterograde amnesic mice.
    Tang YP; Noda Y; Hasegawa T; Nabeshima T
    Br J Pharmacol; 1997 Sep; 122(2):257-64. PubMed ID: 9313933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of 2 antianoxic agents by a method of decreased barometric pressure: demonstration of a different rate of action].
    Truchaud M
    Ann Pharm Fr; 1983; 41(4):321-6. PubMed ID: 6670816
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
    Ritschel WA; Mandybur TI; Grummich KW; Means ED
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):131-4. PubMed ID: 6748817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.
    DeNoble VJ; Repetti SJ; Gelpke LW; Wood LM; Keim KL
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1123-8. PubMed ID: 3714768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H
    Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
    Steinhäuser B
    Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of (-), (+)clausenamide on anisodine-induced acetylcholine decrease and associated memory deficits in the mouse brain].
    Duan W; Zhang J
    Yao Xue Xue Bao; 1998; 33(4):259-63. PubMed ID: 11939064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R; Cattani L; Tomasi AM; Masoni A
    Agressologie; 1978; 19(3):221-5. PubMed ID: 736222
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of clausenamide on anisodine-induced acetylcholine decrease and memory deficits in the mouse brain.
    Duan W; Zhang J
    Chin Med J (Engl); 1998 Nov; 111(11):1035-8. PubMed ID: 11189211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acoustic traumatism with injectable vincamine. Random double blind clinical trial with a complementary comparative element (author's transl)].
    Hennebert D; De Heyn G
    Rev Med Brux; 1982 Jan; 3(1):37-43. PubMed ID: 7038815
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the effect of vincamine teprosilate on behavioural performances of patients affected with chronic cerebrovascular disease.
    Casale R; Giorgi I; Guarnaschelli C
    Int J Clin Pharmacol Res; 1984; 4(4):313-9. PubMed ID: 6500778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebroxine and the treatment of sudden deafness. Apropos of 2 representative cases].
    Van Geert G; Hennebert D
    Brux Med; 1979; 59(11-12):515-23. PubMed ID: 534950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R
    Clin Ter; 1979 Mar; 88(5):461-12. PubMed ID: 466968
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled testing of vincamine with special reference to the flow properties of blood].
    Klein M; Szobor A; Bräuer H
    Med Klin; 1979 Oct; Suppl():29-36. PubMed ID: 542163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.